Related Experiment Video
Updated: Oct 27, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Riminophenazine Derivatives as Potential Antituberculosis Agents: Synthesis, Biological, and Electrochemical
Mpelegeng Victoria Bvumbi1,2,3, Chris van der Westhuyzen2, Edwin M Mmutlane1
1Department of Chemistry, University of Johannesburg, Auckland Park 2006, South Africa.
Researchers developed novel riminophenazine derivatives for tuberculosis treatment. Certain substitutions significantly enhanced antimycobacterial activity, indicating a promising new class of anti-tuberculosis agents.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Antimicrobial Drug Discovery
Background:
- Tuberculosis remains a significant global health threat, necessitating the development of novel therapeutic agents.
- Riminophenazines are a class of compounds with known antimycobacterial properties, but their potential is yet to be fully explored.
- Understanding the structure-activity relationships of riminophenazine derivatives is crucial for optimizing anti-tuberculosis drug candidates.
Purpose of the Study:
- To design and synthesize novel riminophenazine derivatives with diverse structural modifications.
- To investigate the relationship between lipophilicity, redox potential, and antimycobacterial activity of these new compounds.
- To identify promising candidates for the development of new anti-tuberculosis agents.
Main Methods:
- Synthesis of novel riminophenazine derivatives with varied substituents at N-5, C-3, C-8, and pendant aryl groups.
- Evaluation of in vitro antimycobacterial activity against *Mycobacterium tuberculosis* H37Rv.
- Assessment of mammalian cytotoxicity and determination of redox potentials using cyclic voltammetry.
Main Results:
- A series of novel riminophenazine derivatives were successfully synthesized.
- An activity
- cliff
- was observed with C-8 substitution, highlighting specific structural requirements for potent activity.
- Compounds 10l and 10m demonstrated significant antimycobacterial activity (MIC99 ~1 µM) with favorable redox properties.
Conclusions:
- Novel riminophenazine derivatives with ionizable substituents show potential as anti-tuberculosis agents.
- Specific structural modifications, particularly at the C-8 position, are critical for enhancing antimycobacterial efficacy.
- The identified compounds represent a new class of riminophenazines warranting further investigation for tuberculosis therapy.
More Related Videos
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...